×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ATHE – alterity therapeutics limited - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ATHE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
07:43 am
athe
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference [Yahoo! Finance]
Low
Report
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference [Yahoo! Finance]
11/12
07:25 am
athe
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
Low
Report
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
11/10
07:41 am
athe
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System [Yahoo! Finance]
Medium
Report
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System [Yahoo! Finance]
11/10
07:25 am
athe
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
Medium
Report
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
10/31
07:25 am
athe
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
Low
Report
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
10/9
08:01 am
athe
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders [Yahoo! Finance]
Low
Report
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders [Yahoo! Finance]
10/9
07:25 am
athe
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Medium
Report
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
10/2
07:35 am
athe
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Low
Report
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
11:19 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
11/24
11:19 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
11/24
11:19 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
11/24
11:19 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 24
11/21
06:35 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
11/21
06:30 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
11/21
06:23 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
11/21
06:13 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
Low
Report
Form 6-K ALTERITY THERAPEUTICS For: Nov 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/22
Form 6-K ALTERITY THERAPEUTICS For: Apr 22
15.4%
3/26 Form 6-K ALTERITY THERAPEUTICS For: Mar 26 14.1%
1/14 Form 6-K ALTERITY THERAPEUTICS For: Jan 14 10.7%
8/30 Form 6-K ALTERITY THERAPEUTICS For: Aug 30 6.7%
9/9 Form 6-K ALTERITY THERAPEUTICS For: Sep 09 4.4%
11/26 Form 6-K ALTERITY THERAPEUTICS For: Nov 25 3.7%
9/24 Form 6-K ALTERITY THERAPEUTICS For: Sep 24 3.6%
5/22 Form EFFECT ALTERITY THERAPEUTICS 3.4%
5/29 Global Longevity and Anti-Senescence Therapy Market 2019-2023 - Focus on Senolytic drug therapy, Gene therapy, Immunotherapy and Others 3.3%
10/25 Form 6-K ALTERITY THERAPEUTICS For: Oct 25 3.3%
3/26 Form 6-K ALTERITY THERAPEUTICS For: Mar 26 14.1%
1/14 Form 6-K ALTERITY THERAPEUTICS For: Jan 14 10.7%
8/30 Form 6-K ALTERITY THERAPEUTICS For: Aug 30 6.7%
9/9 Form 6-K ALTERITY THERAPEUTICS For: Sep 09 4.4%
11/26 Form 6-K ALTERITY THERAPEUTICS For: Nov 25 3.7%
9/24 Form 6-K ALTERITY THERAPEUTICS For: Sep 24 3.6%
5/22 Form EFFECT ALTERITY THERAPEUTICS 3.4%
5/29 Global Longevity and Anti-Senescence Therapy Market 2019-2023 - Focus on Senolytic drug therapy, Gene therapy, Immunotherapy and Others 3.3%
10/25 Form 6-K ALTERITY THERAPEUTICS For: Oct 25 3.3%
TOP News Decliners
2/27
Form 6-K ALTERITY THERAPEUTICS For: Feb 27
-14.1%
2/7 Form 6-K ALTERITY THERAPEUTICS For: Feb 07 -9.0%
12/23 Form SC 13D/A ALTERITY THERAPEUTICS Filed by: Life Biosciences LLC -8.9%
5/6 Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting -7.4%
5/6 Alterity Therapeutics (ATHE) Presents At American Academy of Neurology Annual Meeting - Slideshow [Seeking Alpha] -5.7%
9/3 Form 6-K ALTERITY THERAPEUTICS For: Sep 03 -5.4%
5/22 Form 424B3 ALTERITY THERAPEUTICS -4.0%
7/31 Form 6-K ALTERITY THERAPEUTICS For: Jul 31 -3.8%
5/13 Form 6-K ALTERITY THERAPEUTICS For: May 12 -3.6%
10/16 Global Longevity & Anti-Senescence Therapy Market Review 2017-2018 and Forecast to 2023 - ResearchAndMarkets.com -3.4%
2/7 Form 6-K ALTERITY THERAPEUTICS For: Feb 07 -9.0%
12/23 Form SC 13D/A ALTERITY THERAPEUTICS Filed by: Life Biosciences LLC -8.9%
5/6 Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting -7.4%
5/6 Alterity Therapeutics (ATHE) Presents At American Academy of Neurology Annual Meeting - Slideshow [Seeking Alpha] -5.7%
9/3 Form 6-K ALTERITY THERAPEUTICS For: Sep 03 -5.4%
5/22 Form 424B3 ALTERITY THERAPEUTICS -4.0%
7/31 Form 6-K ALTERITY THERAPEUTICS For: Jul 31 -3.8%
5/13 Form 6-K ALTERITY THERAPEUTICS For: May 12 -3.6%
10/16 Global Longevity & Anti-Senescence Therapy Market Review 2017-2018 and Forecast to 2023 - ResearchAndMarkets.com -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: